Advocacy intelligence hub — real-time data for patient organizations
Emory University — NA
National Taiwan Normal University — NA
University of Ulm — NA
Mount Sinai Hospital, Canada — PHASE3
Fakultas Kedokteran Universitas Padjadjaran — NA
Assistance Publique - Hôpitaux de Paris — PHASE2
Novo Nordisk A/S — PHASE1
Centre Hospitalier Emile Roux — NA
Nanjing Nutrabuilding Bio-tech Co., Ltd. — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Rebecca J Brown, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
📍 Bethesda, Maryland
Patrick Schrauwen, PhD
Maastricht University Medical Centre
Peter J.H. Jones, PhD
Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
Ralph DeFronzo, MD, MD
University of Texas Health Science Center San Antonio
📍 SAN ANTONIO, TX
Tristan Pascart, MD
Hospital Group of the Catholic Institute of Lille
Leila Azadbakht, PhD
Isfahan University of Medical Sciences